Treating peripapillary choroidal neovascular membranes: A review of the evidence

Eye

Volumn 25, Issue 6, 2011, Pages 675-681

  Jutley, G ^a,a   Tah, V ^b   Lindfield, D ^a   Menon, G ^c  

^a FRIMLEY PARK HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c LUTON AND DUNSTABLE HOSPITAL   (United Kingdom)

Author keywords

choroidal; neovascular membranes; peripapillary; review

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; STEROID; VASCULOTROPIN INHIBITOR; VERTEPORFIN;

CHOROID DISEASE; DRUG TREATMENT FAILURE; ENDOPHTHALMITIS; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; LASER SURGERY; PERIPAPILLARY CHOROIDAL NEOVASCULAR MEMBRANE; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PROGNOSIS; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINOTOMY; REVIEW; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL FIELD;

EID: 79958746234     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.24     Document Type: Review

References (27)

1. Lopez PF, Green R. Peripapillary subretinal neovascularisation-a review. Retina 1992;12:147-171.
2. Ruben S, Palmer H, Marsh RJ. The visual outcome of peripapillary choroidal neovascular membranes. Acta Ophthalmologica 1994;72:118-121. (Pubitemid 24099195)
3. Capone A, Wallace T, Meredith TA. Symptomatic choroidal neovascularisation in blacks. Arch Ophthalmol 1994;112:1091-1097.
4. Aisenbrey S, Gelisken F, Szurman P. Surgical treatment of peripapillary choroidal neovascularisation. Br J Ophthalmol 2007;91:1027-1030. (Pubitemid 47122107)
5. Binder S. Surgical treatment of peripapillary choroidal neovascularisation. Br J Ophthalmol 2007;91:990-991. (Pubitemid 47122097)
6. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68(4):820-823.
7. Gass JDM. Biomicroscopic and histopathological considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol 1994;118:285-289.
8. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: five year results from randomised clinical trials. Arch Ophthalmol 1991;109:1109-1111.
9. Kies JC, Bird AC. Juxtapapillary choroidal neovascularisation in older patients. Am J Ophthalmol 1988;105:11-19. (Pubitemid 18021337)
10. Wolf S, Wald KJ, Remky A, Arend O, Reim M. Evolving peripapillary choroidal neovascular membrane demonstrated by indocyanine green choroidal angiography. Retina 1994;14(5):465-467.
11. Cialdini AP, Jalkh AE, Trempe CL, Nasrallah FP, Schepens CL. Argon green laser treatment of peripapillary choroidal neovascular membranes. Ophthalmic surg. 1989;20:93-99.
12. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy for subfoveal choroidal neovascularisation in age-related macular degeneration: three-year results of an open-label extension of 2 randomised clinical trials-TA P report 5. Arch Ophthalmol 2002;120:1307-1314.
13. Blinder KJ, Shah GK, Thomas MA, Holekamp NM, Joseph DP, Grand G et al. Surgical removal of peripapillary choroidal neovascularization associated with age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:358-364. (Pubitemid 41413189)
14. Rosenblatt BJ, Shah GK, Blinder K. Photodynamic therapy with verteporfin for peripapillary choroidal neovascularisation. Retina 2005;25:33-37. (Pubitemid 40250405)
15. Tewari A, Shah GK, Dhalla MS, Shepherd JB. Combination photodynamic therapy and juxtascleral triamcinolone acetonide for the treatment of aperipapillary choroidal neovascular membrane associated with papilloedema. Br J Ophthalmol 2006;90(10):1323-1324. (Pubitemid 44621501)
16. Bernstein PS, Horn RS. Verteporfin photodynamic therapy involving the optic nerve for peripapillary choroidal neovascularisation. Retina 2008;28:81-84.
17. Uemura A, Thomas MA. Visual outcome after surgical removal of choroidal neovascularisation in pediatric patients. Arch Ophthalmol 2000;118:1373-1378.
18. Mansour AM, Mackensen F, Arevalo F. Intravitreal bevacizumab in inflammatory ocular neovascularisation. Am J Ophthalmol 2008;146:410-416.
19. Almony A, Thomas MA, Atebara NH, Holekamp NM, Del Priore LV. Long-term follow-up of surgical removal of extensive peripapillary choroidal neovascularisation in presumed ocular histoplasmosis syndrome. Ophthalmology 2008;115:540-545.
20. Submacular Surgery Trials Research Group. Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: submacular surgery trials report no. 7. Arch Ophthalmol 2005;123:914-921.
21. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et al. Ranibizumab for neovascular age-related macular degeneration. N Eng J Med 2006;355:1419-1431. (Pubitemid 44511557)
22. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY et al. ANCHOR study group: ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-1444. (Pubitemid 44511558)
23. Nguyen QD, Shah S, Tatlipinar S, Do DV, Anden EV, Campochiaro PA. Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia. Br J Ophthalmol 2005;89:1368-1370. (Pubitemid 41638883)
24. Pederson R, Soliman W, Lund-Anderson H, Larsen M. Treatment of choroidal neovascularisation using intravitreal bevacizumab. Acta Ophthalmologica Scandinavia 2007;85:526-533. (Pubitemid 47163114)
25. Figueroa MS, Noval S, Conteras I. Treatment of peripapillary choroidal neovascular membranes with intravitreal bevacizumab. Br J Ophthalmol 2008;92:1244-1247.
26. Hoeh AE, Schaal KB, Dithmar S. Treatment of peripapillary choroidal neovascularisation with intravitreal bevacizumab. Eur J Ophthalmol 2009;19:163-165.
27. Sho K, Takahashi K, Yamada H, Wada M, Nagai Y, Otsuji T et al. Polypoidal choroidal vasculopathy; incidence, demographic feature and clinical characteristics. Arch Ophthalmol 2003;121:1392-1396. (Pubitemid 37243739)